Literature DB >> 11099616

Technical report: congenital adrenal hyperplasia. Section on Endocrinology and Committee on Genetics.

.   

Abstract

The Section on Endocrinology and the Committee on Genetics of the American Academy of Pediatrics, in collaboration with experts from the fields of pediatric endocrinology and genetics, developed this policy statement as a means of providing up-to-date information for the practicing pediatrician about current practice and controversial issues in congenital adrenal hyperplasia (CAH), including the current status of prenatal diagnosis and treatment, the benefits and problem areas of neonatal screening programs, and the management of children with nonclassic CAH. The reference list is designed to allow physicians who wish more information to research the topic more thoroughly.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11099616

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  10 in total

Review 1.  Congenital adrenal hyperplasia: epidemiology, management and practical drug treatment.

Authors:  D Merke; M Kabbani
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  Adrenal gland: Congenital adrenal hyperplasia: new treatment guidelines.

Authors:  Felix G Riepe
Journal:  Nat Rev Endocrinol       Date:  2010-11-09       Impact factor: 43.330

3.  9alpha-Fluorohydrocortisone therapy in aldosterone synthase deficiency.

Authors:  Ludwig Stapenhorst
Journal:  Pediatr Nephrol       Date:  2005-06       Impact factor: 3.714

Review 4.  Prenatal treatment of congenital adrenal hyperplasia-not standard of care.

Authors:  Selma Feldman Witchel; Walter L Miller
Journal:  J Genet Couns       Date:  2012-05-26       Impact factor: 2.537

5.  Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline.

Authors:  Phyllis W Speiser; Ricardo Azziz; Laurence S Baskin; Lucia Ghizzoni; Terry W Hensle; Deborah P Merke; Heino F L Meyer-Bahlburg; Walter L Miller; Victor M Montori; Sharon E Oberfield; Martin Ritzen; Perrin C White
Journal:  J Clin Endocrinol Metab       Date:  2010-09       Impact factor: 5.958

6.  Neonatal screening of inborn errors of metabolism using tandem mass spectrometry: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2003-05-01

7.  Serum 17 alpha hydroxyprogesterone in normal full term and preterm vs sick preterm and full term newborns in a tertiary hospital.

Authors:  Vasundhara S Chennuri; Shilpa M Mithbawkar; Rajashree A Mokal; Meena P Desai
Journal:  Indian J Pediatr       Date:  2012-08-03       Impact factor: 1.967

Review 8.  Challenges in Prenatal Treatment with Dexamethasone.

Authors:  Bonnie McCann-Crosby; Frank Xavier Placencia; Oluyemisi Adeyemi-Fowode; Jennifer Dietrich; Rachel Franciskovich; Sheila Gunn; Marni Axelrad; Duong Tu; David Mann; Lefkothea Karaviti; Vernon Reid Sutton
Journal:  Pediatr Endocrinol Rev       Date:  2018-09

9.  Corticosteroid physiology and principles of therapy.

Authors:  Priyanka Gupta; Vijayalakshmi Bhatia
Journal:  Indian J Pediatr       Date:  2008-11-21       Impact factor: 1.967

10.  Children with premature pubarche: is an alterated neonatal 17-Ohp screening test a predictive factor?

Authors:  Paolo Cavarzere; Margherita Mauro; Monica Vincenzi; Silvana Lauriola; Francesca Teofoli; Rossella Gaudino; Diego Alberto Ramaroli; Rocco Micciolo; Marta Camilot; Franco Antoniazzi
Journal:  Ital J Pediatr       Date:  2018-01-16       Impact factor: 2.638

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.